The Psychiatrist : Clinical and Therapeutic Journal
Open Access

Major depressive disorder (MDD) is one of the leading causes of disability worldwide, and antidepressant medications remain a key component of treatment [1]. Despite the wide range of antidepressant options available, treatment resistance—defined as the failure to achieve an adequate response after trying two or more different classes of antidepressants—affects a significant portion of the population. Approximately 30% of individuals with depression do not respond to initial antidepressant treatment, and a subset of these patients experience chronic, treatment-resistant depression (TRD). Traditionally, the focus on understanding and overcoming treatment resistance has centered on biological factors, such as genetic variation, neurotransmitter imbalances, and hormonal dysregulation. However [2], recent research has increasingly pointed to the role of psychological factors in influencing treatment outcomes. Among these, personality traits—stable, enduring patterns of thoughts, feelings, and behaviors—are emerging as important variables in understanding why some individuals experience a better response to antidepressant treatment than others. Personality traits, particularly those defined within the Five-Factor Model (FFM), which includes neuroticism, extraversion, openness, agreeableness, and conscientiousness, are believed to influence both the course of depression and the response to treatment. For example, individuals with high levels of neuroticism may be more prone to negative emotional states and have a lower threshold for stress, potentially leading to poorer treatment outcomes. Conversely, traits such as conscientiousness and agreeableness may promote adherence to treatment and enhance the therapeutic relationship, improving the likelihood of positive outcomes. This article explores the relationship between personality traits and resistance to antidepressant treatment, examining how specific traits may contribute to the development of treatment resistance, affect medication adherence, and ultimately influence treatment success [3].

The Role of Personality Traits in Depression and Treatment Response

Personality traits, shaped by genetic, environmental, and experiential factors, play a crucial role in the onset and progression of depressive symptoms. Traits such as neuroticism, which is characterized by a tendency to experience negative emotions like anxiety, sadness, and irritability [4], have been consistently linked to a higher risk of developing depression. Similarly, individuals high in neuroticism may experience greater difficulty in managing stress and coping with life events, which can further exacerbate depressive symptoms. Several studies have shown that individuals with high neuroticism are less likely to respond positively to antidepressant medications. This may be due to a variety of factors, including an increased sensitivity to negative emotional experiences, lower expectations of treatment efficacy, and heightened vulnerability to relapse. Additionally, individuals with high neuroticism may be more likely to engage in maladaptive coping strategies, such as rumination, which can hinder the effectiveness of antidepressant therapy. In contrast, traits such as extraversion and conscientiousness may facilitate better treatment outcomes. Extraverted individuals, who tend to be sociable, energetic, and positive, may have a more optimistic outlook on treatment, leading to greater engagement with the therapeutic process. Similarly, individuals with high conscientiousness—marked by reliability, organization, and persistence—may be more diligent in adhering to prescribed medications and following treatment protocols, which can improve the likelihood of a positive response to antidepressants. Moreover [5], agreeableness, which is associated with being cooperative, empathetic, and trusting, may enhance the therapeutic alliance between patients and healthcare providers. A strong therapeutic alliance has been shown to be a key factor in treatment success, and individuals with high agreeableness may be more open to discussing concerns, adjusting medications, and following the recommended treatment plan, ultimately improving treatment outcomes.

Neuroticism and Treatment Resistance

Neuroticism is one of the most consistently implicated personality traits in the context of treatment resistance. As a trait, neuroticism is characterized by heightened emotional reactivity, sensitivity to stress, and a tendency to experience negative emotions. These tendencies can complicate the treatment process, as individuals high in neuroticism may experience greater distress in response to minor setbacks, leading to poorer engagement with treatment and lower medication adherence [6]. Furthermore, individuals with high neuroticism may have unrealistic expectations about treatment, expecting quick fixes or immediate relief from depressive symptoms. This can lead to premature discontinuation of medications if results are not quickly achieved, contributing to treatment resistance. Additionally, neurotic individuals may have a tendency to catastrophize or engage in rumination, which can perpetuate depressive symptoms and make it more difficult for antidepressants to be effective. Research suggests that individuals high in neuroticism may also have a higher rate of side effects and intolerance to antidepressants, further complicating treatment adherence and success. In these cases, clinicians may need to adopt a more tailored approach to treatment, exploring alternative pharmacological options, adjusting dosages, or incorporating adjunctive treatments such as psychotherapy to address underlying psychological factors.

Extraversion, Conscientiousness, and Medication Adherence

Extraversion and conscientiousness are two personality traits that have been associated with better treatment adherence and more favorable outcomes in antidepressant therapy. Extraverted individuals, who tend to be more optimistic and socially engaged, are likely to view antidepressant treatment as an opportunity for improvement and may be more willing to engage in both pharmacological and psychological interventions. Their positive outlook on treatment can improve motivation and encourage regular medication use, which is critical for achieving remission from depression. Conscientiousness, which is characterized by reliability, attention to detail, and persistence, has been shown to be a strong predictor of treatment adherence. Individuals with high conscientiousness are more likely to follow prescribed treatment regimens, attend appointments regularly, and actively participate in managing their mental health. These behaviors contribute to more successful antidepressant treatment, as consistent medication adherence is essential for achieving and maintaining symptom relief. In contrast, individuals low in conscientiousness may struggle with adherence to treatment, forget to take medications, or become disengaged from the treatment process if they do not see immediate improvements. This lack of adherence can contribute to treatment resistance and may necessitate more intensive interventions to achieve the desired therapeutic effect.

Implications for Personalized Treatment Strategies

Given the relationship between personality traits and antidepressant treatment response, clinicians should consider incorporating psychological factors into the treatment planning process. By assessing personality traits, particularly neuroticism, extraversion, conscientiousness, and agreeableness, clinicians can gain valuable insights into the patient’s likelihood of adhering to treatment and responding to antidepressants. This information can be used to develop personalized treatment strategies that are tailored to the patient’s unique psychological profile. For example, individuals high in neuroticism may benefit from a more gradual approach to medication initiation, with close monitoring of side effects and regular follow-up appointments. Additionally, psychotherapy, such as cognitive-behavioral therapy (CBT), may be beneficial for addressing maladaptive thought patterns, such as rumination, and enhancing coping skills to complement pharmacotherapy. For individuals high in conscientiousness, providing clear instructions, regular check-ins, and encouraging active participation in treatment may optimize medication adherence. Extraverted individuals may benefit from incorporating social support, such as group therapy or family involvement, to bolster their motivation and engagement in the treatment process.

Conclusion

The relationship between personality traits and resistance to antidepressant treatment highlights the importance of considering individual differences when developing treatment plans for patients with depression. Personality traits such as neuroticism, extraversion, conscientiousness, and agreeableness can significantly influence treatment outcomes by affecting medication adherence, treatment expectations, and coping strategies. Understanding these psychological factors can guide clinicians in personalizing antidepressant therapy and improving treatment success for individuals with treatment-resistant depression. By integrating psychological assessments into the treatment process, healthcare providers can enhance their ability to predict treatment response, minimize resistance, and ultimately provide more effective care for patients struggling with depression.

1. McCracken M, DeHaan G, Obedin-Maliver J (2022) Perinatal considerations for care of transgender and nonbinary people: A narrative review.Curr Opin Obstet34: 62-68.

Indexed at, Google Scholar, Crossref

2. Institute of Medicine, Board on the Health of Select Populations, Committee on Lesbian, Gay, Bisexual, and Transgender Health Issues and Research Gaps and Opportunities (2011) The Health of Lesbian, Gay, Bisexual, and Transgender People: Building a Foundation for Better Understanding.  National Academies Press (US), Washington (DC), USA.

Indexed at, Google Scholar, Crossref

3. Dragon CN, Guerino P, Ewald E, Laffan AM (2017) Transgender Medicare beneficiaries and chronic conditions: Exploring fee-for-service claims data.LGBT Health4: 404-411.

Indexed at, Google Scholar, Crossref

4. National Center for Transgender Equality: Washington, DC, USA, 2011.
5. Fredriksen-Goldsen KI, Kim H-J, Bryan AE, Shiu C, Emlet CA (2017)The cascading effects of marginalization and pathways of resilience in attaining good health among LGBT older adults.Gerontologist 57:72-83.

Indexed at, Google Scholar, Crossref

6. Jessen F, Amariglio RE, Van Boxtel M, Breteler M, Ceccaldi M, et al. (2014) A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer’s disease.Alzheimers Dement10: 844-852.

Indexed at, Google Scholar, Crossref